Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of the National Cancer Center
|
August 15, 2025
Decoding the tumor microenvironment: insights into immunotherapy and beyond
Wenhao Xu, Jiahe Lu, Hailiang Zhang, et al.
Frontiers in Oncology
|
September 15, 2023
Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment
Jiahe Lu, Wen-Hao Xu, Hailiang Zhang, et al.
Journal of the National Cancer Center
|
July 22, 2024
Heterogeneity and function of cancer-associated fibroblasts in renal cell carcinoma
Haijia Tang, Wenhao Xu, Jiahe Lu, et al.
Immunological Reviews
|
July 5, 2023
Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy
Wenhao Xu, Wangrui Liu, Jianfeng Yang, et al.
Immunotherapy
|
December 19, 2023
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy
Wenhao Xu, Jianfeng Yang, Shiqi Ye, et al.
Immunotherapy Advances
|
June 27, 2025
Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma
Qintao Ge, Siqi Zhou, Jiahe Lu, et al.
Journal of the National Cancer Center
|
June 12, 2026
Stratification system with tumor-associated macrophages for predicting prognostic and therapeutic implications in clear cell renal cell carcinoma
Jiahe Lu, Shiqi Ye, Zhongyuan Wang, et al.
Medcomm
|
May 21, 2026
Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies
Qintao Ge, Liu Yu, Jiahe Lu, et al.
Theranostics
|
April 30, 2025
Spatially segregated APOE<sup>+</sup> macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma
Qintao Ge, Jialin Meng, Zhongyuan Wang, et al.
Frontiers in Cell and Developmental Biology
|
November 20, 2025
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer
Zhongyuan Wang, Qintao Ge, Anwaier Aihetaimujiang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of the National Cancer Center
|
August 15, 2025
Decoding the tumor microenvironment: insights into immunotherapy and beyond
Wenhao Xu, Jiahe Lu, Hailiang Zhang, et al.
Frontiers in Oncology
|
September 15, 2023
Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment
Jiahe Lu, Wen-Hao Xu, Hailiang Zhang, et al.
Journal of the National Cancer Center
|
July 22, 2024
Heterogeneity and function of cancer-associated fibroblasts in renal cell carcinoma
Haijia Tang, Wenhao Xu, Jiahe Lu, et al.
Immunological Reviews
|
July 5, 2023
Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy
Wenhao Xu, Wangrui Liu, Jianfeng Yang, et al.
Immunotherapy
|
December 19, 2023
Insights into the maturation heterogeneity of tumor-associated tertiary lymphoid structures in cancer immunotherapy
Wenhao Xu, Jianfeng Yang, Shiqi Ye, et al.
Immunotherapy Advances
|
June 27, 2025
Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma
Qintao Ge, Siqi Zhou, Jiahe Lu, et al.
Journal of the National Cancer Center
|
June 12, 2026
Stratification system with tumor-associated macrophages for predicting prognostic and therapeutic implications in clear cell renal cell carcinoma
Jiahe Lu, Shiqi Ye, Zhongyuan Wang, et al.
Medcomm
|
May 21, 2026
Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies
Qintao Ge, Liu Yu, Jiahe Lu, et al.
Theranostics
|
April 30, 2025
Spatially segregated APOE<sup>+</sup> macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma
Qintao Ge, Jialin Meng, Zhongyuan Wang, et al.
Frontiers in Cell and Developmental Biology
|
November 20, 2025
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer
Zhongyuan Wang, Qintao Ge, Anwaier Aihetaimujiang, et al.
Page
of 2